RADELUMIN
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

RADELUMIN Trademark

Serial Number: 79348236 • Registration: 7238476

RADELUMIN is a trademark filed by ABX advanced biochemical; compounds Biomedizinische; Forschungsreagenzien GmbH on March 31, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

ABX advanced biochemical; compounds Biomedizinische; Forschungsreagenzien GmbH (7 trademarks)

Heinrich-Glaeser-Str. 10-14

Entity Type: 99

Trademark Details

Filing Date

March 31, 2022

Registration Date

December 12, 2023

Published for Opposition

September 26, 2023

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 15, 2024 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Mar 15, 2024 XXSS
GENERIC MADRID TRANSACTION CREATED
Mar 15, 2024 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 12, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 12, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 12, 2023 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 26, 2023 NPUB
PUBLISHED FOR OPPOSITION
Sep 26, 2023 PUBO
NOTIFICATION PROCESSED BY IB
Sep 25, 2023 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 6, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 6, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 6, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 22, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 22, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 21, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 21, 2023 TROA
REFUSAL PROCESSED BY IB
Apr 13, 2023 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 17, 2023 RFCS
REFUSAL PROCESSED BY MPU
Mar 16, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 25, 2023 RFCR
NON-FINAL ACTION WRITTEN
Jan 24, 2023 CNRT
ASSIGNED TO EXAMINER
Jan 18, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 6, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 31, 2022 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Aug 30, 2022 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 25, 2022 REPR